Supraventricular Tachycardia
📧 Sign up to get email alerts when something new happens for Supraventricular Tachycardia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-11-27FDA Approved: ADENOSINE — Original Application (Fresenius Kabi USA, LLC)
FDA approved the original application for Adenosine from Fresenius Kabi USA, LLC for injection. The product is used to interrupt paroxysmal …
-
FDA approval · 2017-08-08FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approved Zydus Pharmaceuticals USA's original application for diltiazem hydrochloride as a generic product, enabling its use for the man…
-
FDA approval · 2017-06-08FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical's diltiazem hydrochloride as a generic product under an original ANDA.
-
CLINICAL_TRIALS withdrawal · 2017-05-15Clinical Trial Update: Evaluation of the Pharmacokinetic Profile, Pharmacodynamic Effects, Acceptability and Tolerability of an Oral Amiodarone Solution of 15 mg / mL in Children With Supra Ventricular Tachycardia [Phase 2]
A Phase 2 pediatric trial evaluating the pharmacokinetic, pharmacodynamic, acceptability, and tolerability of an oral amiodarone solution in…
-
FDA approval · 2017-05-05FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Nivagen Pharmaceuticals, Inc.)
The FDA approved the original application for verapamil hydrochloride from Nivagen Pharmaceuticals, Inc. as a generic product.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia [Phase 3]
Phase 3 trial update on intracardiac cryoablation for atrioventricular nodal reentrant tachycardia and related supraventricular tachycardias…
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Dexmedetomidine and Adenosine: Therapeutic Use for SVT [NA]
This completed clinical trial evaluated the combination of dexmedetomidine and adenosine for treating supraventricular tachycardia; results …
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: Supraventricular Tachycardia Collection Study
The Supraventricular Tachycardia Collection Study (NCT02158728) by Medtronic completed and posted results related to supraventricular tachyc…
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: Comparison of Continuous Sternal ECG Patch Monitors (Carnation and Zio) Trial
This clinical trial compared two continuous sternal ECG patch monitors (Carnation and Zio) for detecting arrhythmias in patients with syncop…
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Effectiveness of Calcium Channel Blockers and Adenosine in the Emergency Management of SVT [Phase 4]
The Phase 4 trial evaluated the effectiveness of calcium channel blockers and adenosine in the emergency management of supraventricular tach…
-
FDA approval · 2017-01-23FDA Approved: CARDIZEM CD — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for Cardizem CD (diltiazem hydrochloride) from Bausch Health US LLC under NDA 020062, allowing c…
-
CLINICAL_TRIALS trial_result · 2016-12-22Clinical Trial Update: A Study of Caffeine on Cardiac Arrhythmias [NA]
A completed clinical trial investigates the effects of caffeine on supraventricular tachycardia and atrial fibrillation.
-
FDA approval · 2016-11-18FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals Inc)
FDA approved a supplemental application for Verapamil hydrochloride from Teva Pharmaceuticals Inc.
-
FDA approval · 2016-11-18FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved Oceanside Pharmaceuticals' supplemental application for diltiazem hydrochloride. The approval confirms a modification to the pr…
-
FDA approval · 2016-11-18FDA Approved: CARDIZEM CD — Supplemental Application (Bausch Health US LLC)
FDA approved a supplemental application for Cardizem CD (diltiazem hydrochloride) submitted by Bausch Health US LLC.
-
CLINICAL_TRIALS trial_result · 2016-10-07Clinical Trial Update: Comparison of Continuous Sternal ECG Patch Monitors (Carnation and Zio) Trial
This clinical trial update compares two continuous sternal ECG patch monitors (Carnation and Zio) for detecting arrhythmias in patients with…
-
FDA label_change · 2016-06-29FDA Approved: CARDIZEM CD — Supplemental Application (Bausch Health US LLC)
FDA has approved a supplemental application for Cardizem CD (diltiazem hydrochloride) filed by Bausch Health US LLC under NDA 020062.
-
FDA approval · 2016-05-29FDA Approved: PROPAFENONE HYDROCHLORIDE — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for Propafenone hydrochloride from Strides Pharma Science Limited.
-
FDA label_change · 2016-04-08FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (EXELA PHARMA SCIENCES, LLC)
FDA approved a supplemental application for verapamil hydrochloride, resulting in changes to its labeling.
-
FDA approval · 2016-04-07FDA Approved: ESMOLOL HYDROCHLORIDE IN WATER — Original Application (WG Critical Care, LLC)
FDA approved Esmolol hydrochloride in water as a new drug product under NDA205703 (Original Application) from WG Critical Care, LLC.
-
CLINICAL_TRIALS research · 2016-02-18Clinical Trial Update: Epidemiology of Symptomatic Arrhythmias
This NHLBI-sponsored trial update reports on the epidemiology of symptomatic arrhythmias, including atrial fibrillation and various tachyarr…
-
CLINICAL_TRIALS trial_result · 2016-01-12Clinical Trial Update: Prospective Assessment After Pediatric Cardiac Ablation (PAPCA)
This entry notes a completed prospective clinical trial from Stanford evaluating outcomes after pediatric cardiac ablation (PAPCA).
-
FDA approval · 2015-12-21FDA Approved: INDERAL LA — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approves a supplemental application for Inderal LA (propranolol hydrochloride) by ANI Pharmaceuticals, Inc., granting approval for chang…
-
FDA approval · 2015-11-20FDA Approved: DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for diltiazem hydrochloride extended-release from Oceanside Pharmaceuticals.
-
FDA approval · 2015-10-14FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Verapamil Hydrochloride (generic) from Chartwell RX, LLC.